The strategically positioned Asn355 glycosylation site carrying both hyper-truncated and elongated N-glycans was found to be particularly important for MPO function, a finding that may guide future glycoengineering efforts aiming to generate therapeutically relevant recombinant MPO products with tuneable activity and inhibition potential tailored to specific biomedical applications involving persistent and severe pathogen infections. Here, MPO is linked to infection.